Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMZ1XR5)

Drug Name
SAR-114137 Drug Info
Indication
Disease Entry ICD 11 Status REF
Pain MG30-MG3Z Phase 1 [1]
Cross-matching ID
PubChem CID
9828551
CAS Number
CAS 537706-31-3
TTD Drug ID
DMZ1XR5

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting Cathepsin K (CTSK)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Odanacatib DM1EO3G Osteoporosis FB83.0 Phase 3 [2]
VEL-0230 DMDSC63 Rheumatoid arthritis FA20 Phase 1 [3]
PMID27998201-Compound-12 DM8QZNC Bone cancer 2B5Z Patented [4]
PMID27998201-Compound-5 DMVZ0ND Chronic obstructive pulmonary disease CA22 Patented [4]
PMID27998201-Compound-9 DM1JOZN Rheumatoid arthritis FA20 Patented [4]
PMID25399719-Compound-17 DMRXKJZ N. A. N. A. Patented [5]
PMID27998201-Compound-15 DMOB8LU Pain MG30-MG3Z Patented [4]
Oxotetrahydro-2-H-furo[3.2-b]pyrrol-4(5-H)-yl derivative 1 DM1SH5R Pain MG30-MG3Z Patented [4]
PMID27998201-Compound-8 DMZK0SY N. A. N. A. Patented [4]
PMID27998201-Compound-10 DMVXTIL Osteoporosis FB83.0 Patented [4]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Cathepsin S (CTSS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
RG7625 DMDGPKS Autoimmune disease 4A40-4A45 Phase 2 [6]
VBY- 891 DMTKPH4 Autoimmune diabetes 5A10 Phase 1 [7]
VBY- 036 DMULRYC Neuropathic pain 8E43.0 Phase 1 [8]
VBY-129 DM4YIWK Autoimmune diabetes 5A10 Phase 1 [9]
PMID27998201-Compound-12 DM8QZNC Bone cancer 2B5Z Patented [4]
PMID27998201-Compound-5 DMVZ0ND Chronic obstructive pulmonary disease CA22 Patented [4]
PMID27998201-Compound-9 DM1JOZN Rheumatoid arthritis FA20 Patented [4]
PMID25399719-Compound-17 DMRXKJZ N. A. N. A. Patented [5]
PMID27998201-Compound-17 DMAZVHJ Hair loss ED70 Patented [4]
Phenylalanine derivative 1 DMVYP8K Glioma 2A00.0 Patented [4]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Cathepsin K (CTSK) TTDZN01 CATK_HUMAN Inhibitor [1]
Cathepsin S (CTSS) TTUMQVO CATS_HUMAN Inhibitor [1]

References

1 From laboratory to pilot plant: the solid-state process development of a highly potent cathepsin S/K inhibitor. Eur J Pharm Biopharm. 2013 Apr;83(3):436-48.
2 A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth. Oncol Rep. 2013 May;29(5):2011-8.
3 Discovery and parallel synthesis of a new class of cathepsin K inhibitors. Bioorg Med Chem Lett. 2001 Nov 19;11(22):2951-4.
4 Cathepsin B and L inhibitors: a patent review (2010 - present).Expert Opin Ther Pat. 2017 Jun;27(6):643-656.
5 An updated patent review of calpain inhibitors (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):17-31.
6 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
7 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2353).
8 Clinical pipeline report, company report or official report of ViroBay.
9 Clinical pipeline report, company report or official report of ViroBay.